Because of its potency and selectivity, together with the simplicity of its synthesis, compounds 41 and 45 represent new hits for TRPM8 modulation, which are now being further modified to discover new analogues with improved properties for prospective therapeutic application in pain and cancer. This evidence concerns the gene TRPM8 and cancer.